Ascendis Pharma (ASND) Reports Q2 EPS by EUR (1.46)

Ascendis Pharma (NASDAQ: ASND) reported Q2 EPS of EUR(1.46).

For earnings history and earnings-related data on Ascendis Pharma (ASND) click here.

You May Also Be Interested In

• NVIDIA stock gains as SemiAnalysis sees H2 data center revenue 20% above consensus
• Children with Achondroplasia Treated with TransCon CNP Showed Continued Improvements in Lower Extremity Alignment at Week 104 of the Pivotal ApproaCH Trial
• Nike (NKE) Tops Q4 EPS by 8c